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Summary
We have identified a novel gene, transducin (b)–like 1
(TBL1), in the Xp22.3 genomic region, that shows high
homology with members of the WD-40–repeat protein
family. The gene contains 18 exons spanning ∼150 kb
of the genomic region adjacent to the ocular albinism
gene (OA1) on the telomeric side. However, unlikeOA1,
TBL1 is transcribed from telomere to centromere.
Northern analysis indicates that TBL1 is ubiquitously
expressed, with two transcripts of ∼2.1 kb and 6.0 kb.
The open reading frame encodes a 526–amino acid pro-
tein, which shows the presence of six b-transducin re-
peats (WD-40 motif) in the C-terminal domain. The ho-
mology with known b-subunits of G proteins and other
WD-40–repeat containing proteins is restricted to the
WD-40 motif. Genomic analysis revealed that the gene
is either partly or entirely deleted in patients carrying
Xp22.3 terminal deletions. The complexity of the con-
tiguous gene–syndrome phenotype shared by these pa-
tients depends on the number of known disease genes
involved in the deletions. Interestingly, one patient car-
rying a microinterstitial deletion involving the 3′ portion
of both TBL1 and OA1 shows the OA1 phenotype as-
sociated with X-linked late-onset sensorineural deafness.
We postulate an involvement of TBL1 in the pathogen-
esis of the ocular albinism with late-onset sensorineural
deafness phenotype.
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Introduction
Ocular albinism with late-onset sensorineural deafness
(OASD; MIM 300650) is an X-linked recessive disorder
characterized by ocular albinism and progressive sen-
sorineural hearing loss in the fourth and fifth decades
of life. Men affected with OASD have translucent pale-
blue irides and a reduction in the retinal pigment, with
severe visual impairment. Findings from the otologic ex-
amination are normal; audiometry reveals high-tone sen-
sorineural deafness in affected men in their third and
fourth decades of life. The skin in patients with OASD
is overtly normal but histologic examination reveals the
presence of macromelanosomes in the epidermis, a fea-
ture consistent with ocular albinism of the Nettleship-
Falls type (OA1) (O’Donnell et al. 1976). OASD differs
from the X-linked albinism-deafness syndrome (MIM
30070) by the presence of patchy, cutaneous hypo- and
hyperpigmentation and the absence of significant eye
involvement in the latter disorder. The phenotypic dis-
tinctions between OA1 and OASD suggest that the latter
is an autonomous entity. Winship et al. (1993) reported
a South African OASD kindred (for clinical description
see Winship et al. 1984) showing tight linkage between
OASD and DXS452, an Xp22.3 genetic marker previ-
ously linked to the OA1 locus. Consequently, the gene
associated with OASD is likely to be physically close to
the OA1 gene, raising the hypothesis that OASD and
OA1 are the result of a contiguous-gene syndrome. Al-
ternatively, OASD may represent pleiotropic manifes-
tations of OA1 (Winship et al. 1993).
We have constructed a deletion map of the distal short
arm of the human X chromosome, using DNA from
individuals carrying deletions and translocations (Schae-
fer et al. 1993) involving this region of the genome and
a highly detailed YAC-based physical map of the Xp22
region that spans ∼40 Mb (Ferrero et al. 1995). The
development of these maps was crucial for the identi-
fication of the gene responsible for Kallmann syndrome
(KAL1; Franco et al. 1991), OA1 (Bassi et al. 1995),
X-linked recessive chondrodysplasia punctata (Franco et
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al. 1995), and Opitz G/BBB syndrome (Quaderi et al.
1997). Different strategies have been used in each case,
leading to the identification of several additional genes
(van Slegtenhorst et al. 1994; Schiaffino et al. 1995).
During the effort aimed at the identification of the
OA1 gene, cDNA selection experiments resulted in the
isolation of a novel gene, TBL1, located outside theOA1
critical region on the telomeric side. Here we report the
characterization of this new gene whose sequence shares
homology with members of theWD-repeat–protein fam-
ily, identifying TBL1 as newmember of this large protein
family in eukaryotes. Furthermore, deletion of TBL1, in
an OASD family, suggests its involvement in the path-
ogenesis of the hearing phenotype of this disorder.
Material and Methods
cDNA Identification
Direct cDNA selection was done on a cosmid contig
encompassing the entire OA1 critical region and flank-
ing sequences. The procedure was similar to that de-
scribed by Lovett (1994), starting with primary cDNA
reverse-transcribed frommRNA from several human tis-
sues (brain, skeletal muscle, liver, and kidney).
After two rounds of selection, the enriched cDNApool
was radiolabeled with 32P and was used as a probe for
a Southern blot containing EcoR1-digested cosmids. A
15-kb EcoRI genomic fragment from cosmid 248E4 was
positive to the probe and was used to screen an oligo-
dT–primed human adult retina cDNA library, in
Lambda GT10 (a generous gift from Dr. J. Nathans, The
Johns Hopkins University School of Medicine, Balti-
more). Several cDNA clones were identified and used to
screen cDNA libraries from different tissues.
Phage library plating and screening conditions were
as described elsewhere (Sambrook et al. 1989). Recom-
binant phages recognized by the probes were isolated,
and the insert recovered by EcoRI digestion and sub-
cloned in pBluescript II SK (Stratagene). The mouse
cDNA clone R4 was isolated from a mouse retina cDNA
library, in Lambda ZAP (a kind gift from Dr. Baher,
Baylor College of Medicine, Houston), with use of a
human cDNA clone (AR145, data not shown) as a
probe, spanning portions of the 3′ UTR and the coding
region.
DNA Sequencing
Both manual (with a Sequenase version 2.0 7-deaza-
dGTP DNA sequencing kit fromAmershamLife Science)
and automated (with an Applied Biosystem ABI 377
fluorescent sequencer) sequencing were done on TBL1
cDNA clones, with use of vector and gene-specific oli-
gonucleotide primers. The nucleotide sequence of the
human TBL1 cDNA has been submitted to GenBank
under accession number Y12781.
Computer Sequence Analysis
Sequence assembly and editing was done with both
the AutoAssembler version 1.4 (Perkin Elmer-Applied
Biosystems) and DNA Strider 1.2 programs (Marck
1988). We compared nucleotide and amino acid se-
quences with the nonredundant sequence databases pre-
sent at the National Center for Biotechnology Infor-
mation (NCBI) and at TIGEMNet, using the BLAST
algorithm (Altschul et al. 1990). In particular, Blast-P
searches were done by means of the 2.0 version of
BLAST (Altschul et al. 1997). BLAST searches versus
Drosophila melanogaster sequences were done bymeans
of the Berkeley Drosophila genome project BLAST
server (Rubin 1996).
Gene-prediction analysis was done with the Grail 1.3,
GeneFinder, and GenView programs. We identifiedWD-
40 repeats by using the hidden Markov models (HMM)
search against the PFAM 2.1 database of the most com-
mon protein domains.
The global alignment program (gap; gap weight 
3.0, gap length weight  0.1) and the local alignment
program, Bestfit (gap weight  5.0, gap-length weight
 0.3), were used to analyze identity and similarity
among different nucleotide and amino acid sequences
(Wisconsin Package version 10.0, Genetics Computer
Group). Multiple sequence alignment was done by use
of the Clustal-W algorithm (Thompson et al. 1994).
Expression Analysis of TBL1
Northern blots of poly-(A) RNA, from various hu-
man adult and fetal tissues, were purchased from Clon-
tech and hybridized, as described elsewhere by Sam-
brook et al. (1989). The pool of inserts of a mouse
cochlea cDNA library, in Lambda ZAP II (L. Hampton
and J. Battey, personal communication), was prepared
by use of PCR with 1 # 106 plaque-forming unit and
T3 and T7 vector primers. A 1:20 pool dilution was
then reamplified with Tbl1-specific oligonucleotides and
synthesized on a mouse cDNA clone R4 (see cDNA Iden-
tification section): M176F1 5′-TCATGCAGCACAGA-
CATGTG-3′ and M176R1 5′-TCATGTCATCAGA-
GCAGGAGG-3′.
X-inactivation studies were done by means of RT-
PCR, with a set of primers from the 3′UTR region
(AR10F, 5′ TGCCCTGCCTTCTTACATAAA 3′ and
AR10R, 5′ GTCTGAGATGGAAGCTGTCTT 3′), by
use of cDNA from somatic-cell hybrids retaining only
the active or the inactive X chromosome (Agulnik et al.
1994). RT-PCR experiments were done according to the
manufacturer’s recommended conditions (Gibco BRL).
MIC2 and PGK1 primers and PCR conditions were as
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Figure 1 Genomic structure of TBL1. The orientation of TBL1 with respect to OA1 is shown (top). The number on the top indicates
the distance between the two 3′ ends of the genes. The thin bars in the middle denote the cosmid, and are not drawn to scale. Shown at the
bottom is the genomic structure of TBL1. Dot-filled squares denote untranslated exons, whereas blackened squares denote coding exons. TEL
 telomere and CEN  centromere.
described elsewhere (Brown et al. 1990; Franco et al.
1991). Mouse-embryo sectioning and in situ hybridi-
zation were done as described elsewhere (Rugarli et al.
1993). A subclone of murine Tbl1 (R4) into pBluescript
KS was linearized with an appropriated restriction en-
zyme, to transcribe either a sense or an antisense (35S)-
labeled riboprobe, by use of the Stratagene RNA tran-
scription kit. Slides were exposed for 2–3 wks.
Results
Isolation of Human TBL1
A cosmid contig covering the entire OA1 critical re-
gion and flanking sequences in Xp22.3 (Wapenaar et al.
1993) was chosen for the isolation of transcribed se-
quences. cDNA selection was done with biotinylated
cosmid DNA and double-strand cDNA derived from hu-
man total-embryo RNA. The cDNA, enriched after two
rounds of selection, was used as a probe to hybridize an
EcoRI-digested cosmid contig DNA. A 15-kb EcoRI
fragment (from cosmid 248E4; fig. 1), located outside
the OA1 critical region on the telomeric side, was pos-
itive to the hybridization and was used as a probe to
screen a human embryo cDNA library. Ten positive
clones were obtained and the largest one, 176X (not
shown), was chosen to rescreen an adult retina cDNA
library. Screening of additional cDNA libraries, from
different tissues, allowed us to build a cDNA contig of
5,718 nucleotides. This transcript corresponds to a novel
human gene named “TBL1,” according to the Human
Genome Organization nomenclature committee’s
recommendation.
Two groups of cDNA with poly-A tails were isolated
(the smallest of ∼2.0 kb, and a larger one of 5.7 kb),
consistent with the presence of two transcripts of 6.0 kb
and 2.1 kb as shown in the northern blot analysis (see
Expression Analysis and X-Chromosome–Inactivation
Studies section). A canonical polyadenylation signal was
found only for the longest transcript, at nucleotide 5683.
No canonical polyadenylation site was found in the vi-
cinity of the poly-A tail in the shortest cDNA clones.
Three in-frame ATGs were found in the consensus
cDNA sequence, whereas several in-frame stop codons
were found upstream of the first ATG. The first two
ATGs (nucleotide 478 and 538) were located in exon 4
(nucleotides 436–580 of the cDNA), an alternatively
spliced exon that is not present in three cDNA clones
(data not shown); the third ATG was located in exon 5
at nucleotide position 631. The TAA stop codon was
located at nucleotide 2209 (exon 18).
We identified a portion of the mouse Tbl1 cDNA by
screening a mouse retina cDNA library, using an insert
of a human cDNA clone as a probe spanning the 3′
portion of the coding region. Several positive clones have
been identified and further characterized. One of the
cDNA inserts was used to identify genomic clones,which
allowed us to localize the mouse gene on chromosome
X, band B-C, by FISH (Disteche et al. 1998). Preliminary
sequence-analysis data on the murine Tbl1 clones in-
dicate a very high degree of identity, both at the nucle-
otide and protein levels, between the two species (data
not shown). The homology starts in the human TBL1
cDNA sequence at the third in-frame ATG (exon 5),
whereas no homology can be detected upstream of this
codon (data not shown). This suggests that the third in-
frame ATG is the authentic initiation codon, resulting
in a predicted human TBL1 protein product of 526
amino acids. Sequences related to the mammalian TBL1
gene have been identified in Saccharomyces cerevisiae
and Drosophila melanogaster (see following section). A
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multiple sequence alignment indicates that significant
homology is present along the entire length of the pro-
teins, starting from the methionine corresponding to the
third in-frame ATG in the human gene product (fig. 2A).
On the basis of these observations, the numbering of the
amino acid residues starts from the methionine corre-
sponding to ATG, at nucleotide position 631.
Sequence Analysis and Homology with WD-
40–Repeat Containing Genes
A sequence homology search against the nucleotide
databases maintained at the NCBI revealed the presence
of several human expressed-sequence tags (ESTs) cor-
responding to the query sequence. Analysis of the
UniGene database (UniGene build #31, derived from
GenBank release 105) identified a cluster of ESTs be-
longing to the TBL1 transcript and derived from several
human cDNA libraries. Six independent mapping as-
signments were done by different groups using radiation
hybrid-analysis, allowing the mapping of the transcript
between markers DXS1223–DXS1043, in agreement
with our positional cloning data. Mouse ESTs have also
been identified, which correspond to the mouse Tbl1
transcript.
A BLAST search versus the high-throughput genomic
sequences (HTGS) database revealed that the Xp22.3
region, containing the TBL1 and OA1 genes, is being
sequenced by the Human Genome Center at Baylor Col-
lege of Medicine (Houston) in the context of the ongoing
human genome project. A 320-kb unfinished nucleotide
sequence containing 17 unordered pieces is available un-
der the GenBank accession number AC003978.
A protein database search with use of TBL1 reveals
a significant homology with all WD-40–repeat contain-
ing proteins. The highest homology was detected with
a vegetable-incompatibility protein HET-E-1, from Po-
dospora anserina (L28125); a S. cerevisiae hypothetical
59.1-kd protein of unknown function (S48268); a b-
transducin–like protein from Synechocystis sp.
(D63999); an AAC3 hypothetical protein from Dic-
tyostelium discoideum (S05357); and murine, bovine,
and human Lissencephaly-1 proteins (P43035, P43033,
and P43034, respectively).
We identified six regions of high identity with b-trans-
ducin family WD-40 repeats, using the PFAM database
of the most common protein domains and the HMM
for each (Sonnhammer et al. 1997). The position of the
WD-40 repeats in TBL1 and the alignment to the con-
sensus sequence is shown in figure 2B. Repeats B and E
are less conserved, with respect to the WD-40 consensus
sequence, and show a lower score in the HMM analysis.
Furthermore, repeat E is interrupted by an insertion of
8 amino acids in the middle of the repeat.
After masking all of the WD-40 repeats in the TBL1
polypeptide, we detected significant sequence identity
only with the yeast hypothetical 59.1-kd protein of un-
known function in the VPS15-YMC2 intergenic region
of chromosome II (Mannhaupt et al. 1994). The overall
amino acid sequence identity is 27%, with 36% se-
quence similarity.
Interestingly, a TBLASTN search, done with the
Berkeley D. melanogaster genome project BLAST server
(Rubin 1996), identified a number of D. melanogaster
genomic sequences showing high identity to the human
TBL1 gene. The deduced partial amino acid sequence
shows an extremely high level of sequence identity
(81%) and similarity (84%) with human TBL1. A mul-
tiple sequence alignment among human TBL1, the D.
melanogaster, and S. cerevisiae predicted gene products
is shown in figure 2A.
Expression Analysis and X-Chromosome–Inactivation
Studies
Northern blot analysis, done with a TBL1 cDNA
probe derived from the coding region, showed the pres-
ence of two different transcripts of ∼6.0 kb and 2.1 kb
(fig. 3). The wide variety of adult and fetal tissues show-
ing the presence of the transcripts indicates that the gene
is ubiquitously expressed. Brain and heart samples show
a strong expression only of the smaller transcript,
whereas the upper-size transcript is barely detectable in
these tissues with use of a 3′ UTR probe (data not
shown). The latter probe can detect only the 6.0-kb tran-
script (data not shown).
The mouse cDNA clone R4, encompassing the 3′ por-
tion of the coding region and part of the 3′ UTR, was
used for RNA in situ hybridization on 10.5- and 12.5-
dpc mouse embryonic sections. Consistent with the
northern blot experiment, expression is detectable, in all
tissues, as a diffuse hybridization signal (data not
shown).
Several sets of primers were designed on the nucleotide
sequences of the mouse cDNA clone R4 and mouse EST
clone (IMAGE clone 779831) containing the 5′ region
of the Tbl1 transcript and were used to test the expres-
sion of the gene in a mouse cochlea cDNA library, by
PCR. A clear signal was detected (fig. 4A), indicating
that Tbl1 is expressed in this tissue.
The ability to detect TBL1 expression in cultured cell
lines (lymphoblasts and fibroblasts; data not shown) al-
lowed us to test the X-inactivation status of the gene.
Reverse-transcribed RNA samples from hybrid cell lines
that retain either the active or the inactive X chromo-
some were amplified by PCR, by use of oligonucleotides
AR10F and AR10R from the cDNA sequence. As shown
in figure 4B, specific PCR products were observed in
samples from both the active and the inactive X hybrids,
indicating that this gene escapes X-chromosome inac-
Figure 2 a,Multiple sequence alignment obtained using the Clustal-W algorithm. TBL1 human TBL1 polypeptide; DROME predicted
D. melanogaster protein encoded by P1 clone DS05054, P38262  hypothetical yeast 59.1-kd protein (accession number P38262). Identical
and conserved amino acid residues are boxed in dark and light gray, respectively. Numbering is not reported for the D. melanogaster protein,
because the complete polypeptide could not be predicted from the currently available genomic sequences. The missing amino acid residues, as
well as the gaps inserted by the Clustal-W program, are denoted by dashed lines. b, Position of WD-40 repeats in the TBL1 gene, determined
by the HMM search against PFAM. Scores are expressed in bits (LOD score, in base 2); a score 115 is almost always considered significant.
The amino acid alignment to the consensus sequence of G-b–transducin (WD-40) repeats is shown to the left for each domain.
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Figure 3 Northern blot analysis ofTBL1.The cDNA probe AR145was hybridized to three commercial northern blots (Clontech) containing
2 mg poly-(A) RNA from various human adult (a and b) and fetal (c) tissues. The TBL1 gene is ubiquitously expressed, with two transcripts
of ∼2.1 kb and 6.0 kb. In fetal tissues the smaller transcript seems to be more abundant than the larger one.
tivation. MIC2 and PGK1 control genes showed the
expected amplification product from the hybrid cell
lines.
Genomic Structure and Y-Chromosome Homology
Hybridization of cDNA clones to the cosmid contig
in this region demonstrated that the TBL1 gene spans
∼150 kb of genomic DNA. Sequencing the 5′ UTR of
the gene revealed the presence of a CpG island contain-
ing BssHII, EagI, SmaI, and SacI restriction sites. Unlike
OA1, TBL1 is transcribed from telomere to centromere,
and the distance between the 3′ ends of the two genes
is !6 kb.
EcoRI cosmid fragments hybridizing to cDNA probes
were subcloned in plasmid vectors and sequenced by
means of oligonucleotide primers designed from the
cDNA sequence. Eighteen exons were identified, and the
sequence of all exon-intron boundaries was determined.
Exon sizes and splice-junction sequences are shown in
table 1. Only exon 9 does not show the canonical con-
sensus sequences for splice sites.
Southern blot analysis, done on human genomic DNA
by means of TBL1 cDNA clones as probes, identified
Y-chromosome–specific bands in addition to the X-spe-
cific signals. Homology with the Y chromosome was
then confirmed by fluorescence in situ hybridization, by
means of both the X-specific cosmid 228H8 (encom-
passing part of the coding and the 3′ UTR regions) and
the 1.3-kb EcoRI cDNA fragment from the AR145
cDNA clone (data not shown).
Patient Analysis
We collected DNA from two carrier females and an
affected male of an OASD family (previously described
by Winship et al. 1993), who show the classic OA1
phenotype associated with OASD. Genomic DNA from
this patient and from individuals carrying deletions
spanning the genomic region containing TBL1 (Schaefer
et al. 1993) were analyzed by Southern blot, by means
of several probes from TBL1 cDNA and the flanking
genomic region. As indicated in figure 5,TBL1 is entirely
deleted in patients BA199 (Bassi et al. 1994), BA127,
BA163, and BA38 (Schaefer et al. 1993), whereas it is
partly deleted in the patient with OASD and in patient
BA126. A precise localization of the breakpoint in both
patients was then done by PCR analysis, by means of
primers designed on the exon and intron sequences of
TBL1.
As already reported by Schaefer et al. (1993), patient
BA126 has an interstitial deletion of ∼6 Mb in which
the distal breakpoint is localized between the arylsul-
fatase F and steroid sulfatase genes, whereas the prox-
imal breakpoint had been localized distal to OA1. We
found that the proximal breakpoint is located within the
3′ portion of the coding region of TBL1, between exons
15 (deleted) and 16 (still present); therefore, the patient
retains only the last three exons of the gene.
A preliminary characterization of a patient with
OASD with a gene deletion, by means of Southern anal-
ysis with TBL1 and flanking sequences including the
OA1 gene as probes, indicated that the interstitial de-
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Figure 4 A, Tbl1 expression in a mouse cochlea cDNA library,
as detected by PCR (see Material and Methods). The positive control
R4 represents a clone obtained from a mouse retina cDNA library. B,
Inactivation status of TBL1. Oligonucleotide primers from the 3′ UTR
region of TBL1 and from the human PGK1 and MIC2 genes were
used for the RT-PCR amplification of hamster/human cell hybrids re-
taining the human active (Xa) or inactive (Xi) X chromosome. Ha 
parent hamster line (a plus sign [] and a minus sign [] indicate the
presence or absence of reverse transcriptase [RT] in the RT reaction,
respectively); Hu  human genomic DNA; H2O  no DNA added;
and Mw  molecular-weight marker. A 341-bp PCR product was
observed in samples from both the active and the inactive X hybrids,
indicating that TBL1 escapes X-chromosome inactivation.
Table 1
Splice-Site Junctions of TBL1
Exon
Number
3′ Splice
Site
5′ Splice
Site
Exon
Size
1 ) GACGAGgtgagtgcgc )
2 tttcttccagATTTCC TGAAAGgtacagaaaa 72
3 ttcagggtagGCTGGT CATAAGgtaagcagcc 88
4 gttccaccagGAGCCC GGAGAGgtactgcggt 144
5 ttttgaacagAGGGTG AGTCAGgtaagaggct 107
6 gccacaccagGTTTTT AACGAGgtacgtagct 145
7 ttgttcccagGATGGC CAGTCAgtgagtgcag 257
8 gctgtgacagATATAA CTCCGGgtaaggactg 133
9 gaactagtggATCTGG TGGAATgtaagcatct 141
10 tggccctcagACCAAT AAGATGgtgagttctg 63
11 ttactaacagGTAACC GACAAAgtgagtatta 97
12 cggaacacagACAACA ATTCAGgtgagttttt 61
13 cctactgcagCCCCTG CACACAgtaagtgaga 121
14 tctctttcagAACGAG TTGAAGgtagagtcgg 74
15 tgttctgtagATCTGG GGCAAGgtaagggcag 127
16 accttgctagTGCTTC ACTCAGgtaagctccc 166
17 tgctttcagAGTGGA GGCTCTgtaagcaaca 102
18 ttccttccagGTGTGT ) )
NOTE.—Captial letters denote exonic sequences and lowercase
letters denote intronic sequences.
letion found in this patient extends from the most 3′
region of TBL1 into the OA1 gene. PCR analysis with
exon-specific primers shows that the patient is missing
the last five exons (14–18) of TBL1 and the last three
exons (7–9) of OA1 (data not shown). The availability
of the nucleotide sequence AC003978, covering part of
the TBL1 and OA1 genomic regions, allowed us to de-
sign a number of oligonucleotide primers in an attempt
to amplify the breakpoint of the patient with OASD.
Primers 12intfl intron 12 of TBL1) and 6int (intron 6
of OA1), which are normally 39.8 kb apart on genomic
DNA, successfully amplified a 630-bp PCR product in
the patient with OASD and in the carrier mother. Fur-
thermore, we tested the segregation of the PCR fragment
containing the deletion breakpoint, on all the family
members available, and confirmed that the deletion is
present in all affected males and all carriers (fig. 6). No
amplification was observed in several control DNA. Se-
quence analysis of the fragment shows that the break-
point occurs within exon 13 at nucleotide 1630 of TBL1
cDNA on the telomeric side, and 189 bp downstream
of exon 6 (OA1) on the centromeric side. Therefore, the
patient retains the first 12 exons and 40 bp of exon 13
of TBL1 and the first 6 exons of OA1. On the TBL1
side, the deletion breakpoint generates a hypothetical
chimeric protein comprising the first 333 amino acids
of TBL1 plus 58 amino acids encoded by the adjacent
intron 6 of theOA1 gene. Overall, the deletion removes
38.3 kb of genomic DNA. Repeated elements, possibly
predisposing the rearrangement, are present in TBL1
intron 12 and in OA1 intron 6 in the vicinity of the
deletion breakpoints. Furthermore, a dinucleotide TT
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Figure 5 Schematic deletion map surrounding the TBL1 locus. Heavy bars represent the portion of the X chromosome still present in
the patient, whereas dashed lines indicate either X-Y translocation (patient BA127) or microinterstitial deletion (patients BA199, BA163,BA126).
The entire genomic region is not drawn to scale. KAL  Kallmann syndrome 1 gene, TBL1  transducin b–like 1, OA1  X-linked ocular
albinism gene, APXL  apical protein from xenopus-like, and CLCN4  voltage-gated chloride channel 4. Patients’ clinical phenotypes are
shown on the left, as follows: SS  short stature, CDPX  X-linked chondrodysplasia punctata, MRX  nonspecific mental retardation, XLI
 X-linked ichthyosis, KAL Kallmann syndrome; OASD ocular albinism with late-onset sensorineural deafness, and OA1 ocular albinism
of the Nettleship-Falls type. TEL  telomere and CEN  centromere.
sequence is flanking the deletion on both sides, whereas
in the rearranged sequence only two Ts are present (fig.
7). Comparison between the genomic sequence
AC003978 and the 12intfl-6int amplification fragment
in the OASD patient shows a 3-bp deletion in a stretch
of As (in TBL1 intron 12, located 300 bp upstream of
the breakpoint) and a 2-bp substitution, which likely
represent polymorphic variants.
Besides removing a portion of TBL1 and OA1, the
deletion identified in the patient with OASD removes a
5,700-bp region that lies between the 3′ ends of the two
genes. About 35% of this genomic region contains in-
terspersed repeat elements, for a total of 1,991 bp. These
include a MER2-type repeat (269 bp), a portion of a
Mariner transposon (1,242 bp), and two ALU sequences
(480 bp).
Extensive sequence analyses have been performed on
the intragenic nucleotide sequence, after masking the re-
peat elements. These include BLAST homology searches
versus both nucleotide (nonredundant nucleotide data-
base, dbEST, HTGS, and genome survey sequence) and
protein databases. No significant sequence matches have
been identified, indicating that (1) no transcripts ho-
mologous to known sequences are present in the query
sequence and (2) no evolutionary conserved sequences
can be identified when comparing the query sequence
with model organism sequences. Moreover, gene-pre-
diction analysis failed to reveal any high-scoring exons
that are commonly detected by more than one program
(data not shown). Therefore, we can reasonably rule out
the presence of other genes within the deleted region.
Discussion
Progressive hearing loss is a very common disorder in
humans. Sixteen percent of adults, and 130% of those
aged 60 years, have a hearing loss of 25 decibels
(Davis 1989). Currently, little is known about the causes
for this progressive loss, other than it is highly hetero-
geneous and is a result of both environmental and ge-
netic influences.
X-linked deafness accounts only for a small number
of cases of hearing impairment. However, because of its
characteristic pattern of inheritance, several large fam-
ilies have been found and subsequently studied.
In this paper we describe the isolation of a novel X-
linked gene, TBL1, which is located 5.7 kb distal to the
OA1 gene in the Xp22.3 region. In addition, we dem-
onstrate that a microinterstitial deletion removes the 3′
portion of both the OA1 and TBL1 genes in a patient
showing OA1 phenotype associated with X-linked
OASD. These data support the possibility that altera-
tions in TBL1 are responsible for hearing impairment
in this patient.
Unlike OA1, TBL1 is transcribed from telomere to
centromere. It is widely expressed in all tested tissues,
with two transcripts of 2.1 and 6.0 Kb owing to the
presence of an alternative 3′ polyadenylation site. The
smaller transcript seems to be more abundant than the
large one, particularly in the fetal tissues. In contrast to
the OA1 gene, TBL1 is ubiquitously expressed and es-
capes X-chromosome inactivation. Interestingly, all
known genes in Xp22.3 telomeric to TBL1 escape X-
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Figure 6 A, Pedigree of OASD family. Asterisks (*) indicate the DNA samples analyzed in B. Arrows indicate the proband and the carrier
mother whose PCR products were sequenced (see fig. 7). B, Segregation of the deletion breakpoint–containing fragment, as detected by PCR
on genomic DNA in all affected males, carrier females, and normal controls (C). H2O  no DNA added. The numbers at the top of the lanes
indicate the generation number and the individual number, respectively.
chromosome inactivation, whereas genes more centro-
meric are mostly expressed from the active X chromo-
some only. TBL1 and OA1 thus define a chromosomal
boundary that might be relevant in the elucidation of
the molecular mechanisms controlling the spreading of
X-chromosome inactivation.
TBL1 encodes a putative protein of 526 amino acids,
showing a significant homology to the WD-40–repeat
containing proteins, owing to the presence of six WD-
40 repeats in the C-terminal portion of the predicted
protein. Homology could be detected, outside the WD-
40 repeats, with both yeast andD.melanogasterputative
proteins of unknown function. These amino acid se-
quences are deduced from genomic sequences, by use of
gene-prediction programs. In particular, the sequence
identity between TBL1 and the fruit fly protein is 180%,
indicating a high degree of conservation during
evolution.
The WD-repeat motif, or b-transducin domain, is ∼40
amino acids long and contains a number of conserved
amino acids, including a Trp-Asp dipeptide, the “WD”
that frequently terminates the repeat (Neer et al. 1994).
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Figure 7 Localization of the chromosomal breakpoint in a patient with OASD, and schematic representation of a submicroscopic deletion
in the patient and nucleotide sequence of the junction fragment. The size of the deleted region and the position of the 12intfl (intron 12 of
TBL1) and 6int (intron 6 of OA1) primers used for the amplification are shown (top). Primer sequences are as follows: 12intfl, 5′-GTGCAA-
GAAGTGTCACGGAG; and 6int, 5′-AGACTGTGCTAGGTGCCCTT. Unblackened squares denote the exons of both genes deleted in the
patient, whereas blackened squares denote the deleted ones. The size of the amplification product in the patient (middle) and the sequence of
the junction fragment at the breakpoint (bottom) are shown. The dinucleotide TT, present at the breakpoint, is denoted by an unblackened
square. TEL  telomere and CEN  centromere.
Initially identified by sequence homology within trans-
ducin G-protein b-subunits and CDC4 (Fong et al.
1986), sets of 4–8 WD repeats have since been found
in the sequences of 1200 other eukaryotic proteins. Al-
though proteins belonging to this family do not share
any functional activity, all WD-repeat proteins seem to
be regulatory and none are enzymes. They are grouped
into two major classes: one in which the proteins are
composed almost entirely of the repeat domain, and a
second in which the repeats are restricted to the C-ter-
minal domain (Spevak et al. 1993). Proteins in the first
group are known to serve as b-subunits in the hetero-
trimeric G-protein complexes that transduce receptor-
generated signals. Mammalian b-transducins and S. cer-
evisiae Ste4 fall into this class. Proteins in the second
group are involved in activities as diverse asmicrotubule-
dependent processes (Cdc20), catabolite repression
(Tup1), regulation of the RAS-cAMP pathway (Msi1),
RNA splicing (Prp4), DNA replication (Cdc4), and neu-
rogenesis (E-spl) (Spevak et al. 1993). There is no evi-
dence that proteins of this group form part of the het-
erotrimeric G-protein complexes. The repeat is
nevertheless expected to be involved in protein–protein
interactions, as demonstrated for the transducin b-
g–subunit complex (Sondek et al. 1996).
On the basis of the homology data, the TBL1 protein
seems to be more closely related to members of the fam-
ily other than the GTP-binding protein b-subunit sub-
group. The presence of the WD-repeat suggests that
TBL1 might interact with other proteins in a manner
that was described for the transducin b-g–subunit com-
plex (Sondek et al. 1996). These studies revealed that
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the structure of the b-subunit of transducin is a seven-
bladed b-propeller, which is partially encircled by an
extended g-subunit. The b-propeller, which contains
seven structurally similar WD repeats, defines the stereo-
chemistry of the WD repeat and the probable architec-
ture of all WD-repeat–containing proteins. It is not
known whether any other WD protein requires the
equivalent of a g-subunit to fold correctly. Some amino-
or carboxy-terminal extensions may act as built-in g-
subunit equivalents and promote the folding of the re-
peating units.
The finding of a patient affected by ocular albinism
and late-onset sensorineural deafness, carrying a mi-
crointerstitial deletion involving the 3′ portion of both
OA1 and TBL1, needs to be carefully evaluated. Patients
with OASDmanifest high-frequency hearing loss in their
fourth or fifth decade of life, and only an accurate au-
diometry test performed in the fourth decade can reveal
the onset of the disease.
As shown in Results and in figure 5, other patients
available in our collection (Wapenaar et al. 1993) have
either partial (patient BA126) or entire deletions (pa-
tients BA199, BA163, BA38, and BA127) of TBL1 and
apparently do not show any sign of deafness. Owing to
the late onset of sensorineural deafness in patients with
OASD, the age of these patients becomes crucial. As of
this writing, only one patient has passed the third decade
(patient BA127; aged 140 years). Unfortunately, he
never underwent an audiometry test, and several at-
tempts to have him reexamined have failed. Another
patient, BA199, who is aged 38 years, has normal au-
ditory function. Given the broad range of age at onset
of deafness, even a negative result with the audiometry
test does not represent reliable and definitive informa-
tion. Furthermore, it might be difficult to establish
whether the deletion of the TBL1 gene in some of these
patients results in recognizable phenotypic conse-
quences. The phenotype of four patients (patients
BA126, BA127, BA163, and BA38) is in fact quite com-
plex, because of the deletion of from three to six disease
genes, resulting in a contiguous-gene syndrome. The
complexity of the phenotype observed in these patients
(involving mental retardation in three cases) may hide
the presence of other, more subtle, conditions and lead
to an incorrect diagnosis. Therefore, at this stage, the
data we have generated indicate that the different com-
ponents of the phenotypic profile in patients with OASD
(ocular albinism and late-onset sensorineural deafness)
are the consequence of a contiguous microdeletion in-
volving two genes in Xp22.3, OA1 and TBL1.
It has been suggested in the past that OA1 and sen-
sorineural deafness may be allelic and thus result from
the pleiotropic effect of mutations in the OA1 gene. If
this were true, a subset of patients affected with OA1
would also show the clinical features of hearing loss
present in OASD. In a recent survey, Schnur et al. (1998)
describe the deletion and mutation analysis in 29 un-
related North American and Australian patients affected
with X-linked ocular albinism. Although a number of
nonocular phenotypic abnormalities were reported, no
hearing impairment was detected.
Therefore, the hypothesis of a contiguous-gene dele-
tion involving OA1 and TBL1 in the pathogenesis of
OASD appears plausible. Furthermore, the finding of
Tbl1 expressed in the mouse cochlea supports this
conclusion.
Two nonsyndromic loci for X-linked deafness have
been assigned to the short arm of the X chromosome:
DFN4 (Xp21.2, between markers DXS997 and
DXS992; Lalwani et al. 1994) and DFN6 (Xp22, be-
tween markers DXS7108 and DXS7105; del Castillo et
al. 1996), both representing sensorineural-type deafness.
The location ofTBL1, outside the critical regions of both
DFN4 and DFN6, makes the involvement of TBL1 in
these disorders extremely unlikely. Although additional
evidence is needed to formally prove the involvement of
TBL1 in hearing loss, the data presented here indicate
that this new gene represents a promising candidate for
X-linked late-onset sensorineural deafness.
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